Benefit Of Cancer Prevention Surgery Differs Between Women With BRCA1 And BRCA2 Mutations

The surgical removal of the ovaries has been widely adopted as a cancer-risk-reducing strategy for women with either BRCA1 or BRCA2 mutations. A new multicenter study led by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) is the first prospective examination of the impact of this procedure in which BRCA2 mutation carriers were analyzed separately from BRCA1 mutation carriers.

More: continued here

Filed under: Cancer on February 12th, 2008